Researchers investigated the association between newer dipeptidyl-peptidase 4 (DPP-4) inhibitors and the risk of developing bullous pemphigoid among patients with diabetes.   READ MORE

Collaborating Associations

Business Insider Series

The Dermatologist spoke with Adam Friedman, MD, FAAD, professor of dermatology at George Washington School of Medicine and Health Science and director of the supportive oncodermatology clinic, about supportive oncodermatology and its role in cancer treatment.

Aesthetics Corner

Antioxidants plus devices yield optimal aesthetic outcomes.